• pic_main1n
  • pic_main1
  • pic_main2
  • pic_main3
  • pic_main4
  • pic_main5
  • pic_main6
  • pic_main7
  • pic_main8
  • pic_main9
  • pic_main10
  • pic_main11
pic_main1n1 pic_main12 pic_main23 pic_main34 pic_main45 pic_main56 pic_main67 pic_main78 pic_main89 pic_main910 pic_main1011 pic_main1112
carousel jquery by WOWSlider.com v5.4
Cancer Biology (Research)-Lab-III
Academic Staff
Dr. Franky Shah, PhD
Senior Scientific Officer &
Head of Molecular Diagnostics & Research Lab III
Dr. Apexa D. Pandit, Ph.D.
Research Assistant
Dr. Jigna S. Joshi
Junior Research Assistant
Contact Details
Department of Cancer Biology (Research)-Molecular Diagnostics and Research Lab III

Direct :
079-22688000 ; 079-22690000



Immunohematology Lab

      Molecular Diagnostics & Research
Lab - I
Lab - II
Cytogenetics Lab

Lab - III

Facility Available:


  1. Realtime PCR, Agilent
  2. Tissue Disruptor, Genetix
  3. Fluorescence Microscope, DeWinter
  4. Geldoc System, Bio-Rad
  5. CO2 incubator, ESCO

Scope of Activity:

  • Diagnostics: Real time PCR test/ Molecular test for EGFR exon study
  • Research: Various projects are being carried out in majorly three malignancies i.e. Breast Cancer, Oral cancer and lung cancer. The research activities mainly involve studies of stem cell pathways, signal transduction pathways, Genetics, epigenetics, mutational analysis, proteomics and DNA damage and repair mechanism.
  • Academics: All three faculties are involved in the lectures, practical and examination duties of M.Sc. cancer biology course and training the DM Oncopathology students for molecular biology techniques
  • Currently three PhD students are registered under Dr. Franky Shah (Guide: Ph.D. (life science)) .

Strength / Workload: 240 to 260 patients came for EGFR mutation test every year

Diagnostic : Molecular test for EGFR exon study for the lung cancer patients

Area of Interest: The group is keenly interested in studying the various stem cell related pathways and the mechanism for therapy resistance, epigenetics involved in the cancer development and progression, molecular pathogenesis of hereditary breast and ovarian cancer, signal transduction pathways and their interactions circuits, and DNA damage and repair mechanism involved in cancer development and advancement.

OPD Information

NABH Certified

Ethics Committee Accredited for NABH

ISO 15189:2012
@ The Gujarat Cancer & Research Institute, All Rights Reserved.